AAAAAA
Results:
1-8
|
Results: 8
Authors:
McClung, MR
Geusens, P
Miller, PD
Zippel, H
Bensen, WG
Roux, C
Adami, S
Fogelman, I
Diamond, T
Eastell, R
Meunier, PJ
Reginster, JY
Wasnich, RD
Greenwald, M
Kaufman, J
Chestnut, CH
Citation: Mr. Mcclung et al., Effect of risedronate on the risk of hip fracture in elderly women, N ENG J MED, 344(5), 2001, pp. 333-340
Authors:
Ravn, P
Weiss, SR
Rodriguez-Portales, JA
McClung, MR
Wasnich, RD
Gilchrist, NL
Sambrook, P
Fogelman, I
Krupa, D
Yates, AJ
Daifotis, A
Fuleihan, GE
Citation: P. Ravn et al., Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal, J CLIN END, 85(4), 2000, pp. 1492-1497
Authors:
McClung, MR
Citation: Mr. Mcclung, Clinical risk factors and evaluation of the risk of osteoporosis in clinical, ANN MED IN, 151(5), 2000, pp. 392-398
Authors:
Cook, DJ
Guyatt, GH
Adachi, JD
Epstein, RS
Juniper, EF
Austin, PA
Clifton, J
Adachi, JD
Rosen, CJ
Kessenich, CR
Stock, JL
Overdorf, J
Miller, PD
Erickson, AL
McClung, MR
McClung, BL
Griffith, LE
Guyatt, GH
Cook, DJ
Ioannidis, G
Adachi, JD
Guyatt, GH
Citation: Dj. Cook et al., Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group, OSTEOPOR IN, 10(3), 1999, pp. 207-213
Authors:
Meunier, PJ
Delmas, PD
Eastell, R
McClung, MR
Papapoulos, S
Rizzoli, R
Seeman, E
Wasnich, RD
Citation: Pj. Meunier et al., Diagnosis and management of osteoporosis in postmenopausal women: Clinicalguidelines, CLIN THER, 21(6), 1999, pp. 1025-1044
Authors:
McClung, MR
Citation: Mr. Mcclung, Therapy for fracture prevention, J AM MED A, 282(7), 1999, pp. 687-689
Authors:
Metz, JA
Morris, CD
Roberts, LA
McClung, MR
McCarron, DA
Citation: Ja. Metz et al., Blood pressure and calcium intake are related to bone density in adult males, BR J NUTR, 81(5), 1999, pp. 383-388
Authors:
Ravn, P
Bidstrup, M
Wasnich, RD
Davis, JW
McClung, MR
Balske, A
Coupland, C
Sahota, O
Kaur, A
Daley, M
Cizza, G
Citation: P. Ravn et al., Alendronate and estrogen-progestin in the long-term prevention of bone loss: Four-year results from the early postmenopausal intervention cohort study - A randomized, controlled trial, ANN INT MED, 131(12), 1999, pp. 935
Risultati:
1-8
|